Alimentary Pharmacology & Therapeutics

Nutritional status and prognosis in cirrhotic patients
pp. 563-572(10)
Authors: GUNSAR, F.; RAIMONDO, M. L.; JONES, S.; TERRENI, N.; WONG, C.; PATCH, D.; SABIN, C.; BURROUGHS, A. K.

Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong
pp. 573-583(11)
Authors: CHEUNG, T.-K.; LAI, C.-L.; WONG, B. C.-Y.; FUNG, J.; YUEN, M.-F.

Rates and predictors of hepatitis C virus treatment in HCV-HIV-coinfected subjects
pp. 585-591(7)
Authors: BUTT, A. A.; JUSTICE, A. C.; SKANDERSON, M.; GOOD, C.; KWOH, C. K.

Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study
pp. 593-600(8)
Authors: BONNY, C.; FONTAINE, H.; POYNARD, T.; HÉZODE, C.; LARREY, D.; MARCELLIN, P.; BOURLIÈRE, M.; BRONOWICKI, J. P.; MERLE, P.; ZARSKI, J. P.; SAPEY, T.; GUILLEMARD, C.; UGHETTO, S.; HENQUELL, C.; NICOLAS, C.; ROCHE, C.; RANDL, K.; BOMMELAER, G.; ABERGEL, A.

Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial
pp. 601-611(11)
Authors: ROMERO, G.; KRAVETZ, D.; ARGONZ, J.; VULCANO, C.; SUAREZ, A.; FASSIO, E.; DOMINGUEZ, N.; BOSCO, A.; MUÑOZ, A.; SALGADO, P.; TERG, R.

Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea
pp. 613-619(7)
Authors: YEARSLEY, K. A.; GILBY, L. J.; RAMADAS, A. V.; KUBIAK, E. M.; FONE, D. L.; ALLISON, M. C.

Antireflux surgery for non-erosive and erosive reflux disease in community practice
pp. 621-632(12)
Authors: THIBAULT, R.; CORON, E.; SÉBILLE, V.; SACHER-HUVELIN, S.; BRULEY DES VARANNES, S.; GOURNAY, J.; GALMICHE, J. P.

Clinical outcome in upper gastrointestinal bleeding complicating low-dose aspirin and antithrombotic drugs
pp. 633-636(4)
Authors: TAHA, A. S.; ANGERSON, W. J.; KNILL-JONES, R. P.; BLATCHFORD, O.

Impact of Helicobacter pylori on the management of dyspepsia in primary care
pp. 637-641(5)
Authors: BENNETT, K.; FEELY, J.; THORNTON, O.; DOBSON, M.; O'MORAIN, C. A.; O'CONNOR, H. J.

The ¹³carbon urea breath test for the diagnosis of Helicobacter pylori infection in subjects with atrophic gastritis: evaluation in a primary care setting
pp. 643-650(8)
Authors: KORSTANJE, A.; VAN EEDEN, S.; OFFERHAUS, G. J. A.; SABBE, L. J. M.; DEN HARTOG, G.; BIEMOND, I.; LAMERS, C. B. H. W.

Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor
pp. 651-660(10)
Authors: HARBORD, M. W. N.; MARKS, D. J. B.; FORBES, A.; BLOOM, S. L.; DAY, R. M.; SEGAL, A. W.

Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients
pp. 661-667(7)
Authors: ARTS, J.; VAN GOOL, S.; CAENEPEEL, P.; VERBEKE, K.; JANSSENS, J.; TACK, J.

The 5-HT₄ antagonist R216073 does not affect gastric motor and sensory function in patients with functional dyspepsia
pp. 669-677(9)
Authors: VAN LELYVELD, N.; TER LINDE, J.; BARON, A.; MUNDT, M.; WAJS, E.; SAMSOM, M.

Effect of repeated capsaicin ingestion on intestinal chemosensation and mechanosensation
pp. 679-686(8)
Author: HAMMER, J.

Evaluation of topical pharyngeal anaesthesia by benzocaine lozenge for upper endoscopy
pp. 687-694(8)
Authors: SHAOUL, R.; HIGAZE, H.; LAVY, A.

Re-infection following successful eradication of Helicobacter pylori infection
pp. 695-696(2)
Author: Saad, R. A.

Re-infection following successful eradication of Helicobacter pylori infection: authors' reply
pp. 696-698(3)
Authors: Cameron, E. A. B.; Bell, G. D.

Statins for non-alcoholic fatty liver disease: a new indication?
pp. 698-699(2)
Authors: Liberopoulos, E. N.; Athyros, V. G.; Elisaf, M. S.; Mikhailidis, D. P.